<DOC>
	<DOCNO>NCT01985165</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Imrecoxib treatment patient knee osteoarthritis .</brief_summary>
	<brief_title>A Phase 4 Study Imrecoxib Treatment Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Aged form 18 year 75 year old Diagnosed osteoarthritis knee accord American College Rheumatology Functional capacity class ⅠⅢ Unstable angina History myocardial infarction within last 6 month Stroke 6 month screen New York Heart Association class ⅢⅣ congestive heartfailure Systolic blood pressure＞180mmHg , and/or Diastolic blood pressure＞100mmHg Peptic ulcer Known contraindication nonsteroidal antiinflammatory drug（NSAID） Received aspirin within 3 day baseline visit Aspirin dosage &gt; 150mg/d Known Allergic sulfa COX2 inhibitor Pregnancy lactation Glutamicoxaloacetic transaminase and/or glutamicpyruvic transaminase＞2 time upper limit normal Blood urine nitrogen＞1.5 time upper limit normal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>